Effectiveness and Safety of Tralokinumab for the Elderly with Atopic Dermatitis in a Real-World Setting-IL AD.

作者信息

Lauletta Giuseppe, Potestio Luca, Patruno Cataldo, Ferrucci Silvia Mariel, Angileri Luisa, Barei Francesca, Ortoncelli Michela, Ribero Simone, Girolomoni Giampiero, Malagoli Piergiorgio, Pezzolo Elena, Narcisi Alessandra, Gargiulo Luigi, Guanti Mario Bruno, Musumeci Maria Letizia, Ortega Romina, Gurioli Carlotta, Campanati Anna, Caroppo Francesca, Legori Agostina, Rossi Mariateresa, Tolino Ersilia, D'Erme Angelo Massimiliano, Milanesi Nicola, Sciarrone Claudio, Gola Massimo, Magnaterra Elisabetta, Grieco Teresa, Satolli Francesca, Loconsole Francesco, Brianti Pina, Stingeni Luca, Hansel Katharina, Bertoldi Alberto Maria, Napolitano Maddalena

机构信息

Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Department of Medicine and Health Sciences "Vincenzo Tiberio", University of Molise, Campobasso, Italy.

出版信息

Dermatitis. 2025 Jun 5. doi: 10.1089/derm.2025.0129.

DOI:10.1089/derm.2025.0129

PMID:40470535

Abstract

摘要

相似文献

Effectiveness and Safety of Tralokinumab for the Elderly with Atopic Dermatitis in a Real-World Setting-IL AD.

Dermatitis. 2025 Jun 5. doi: 10.1089/derm.2025.0129.

Effectiveness and safety of tralokinumab treatment for moderate-to-severe atopic dermatitis in real-world clinical practice in Japan.在日本的真实临床实践中，特利鲁单抗治疗中重度特应性皮炎的有效性和安全性。

Eur J Dermatol. 2024 Oct 1;34(5):525-532. doi: 10.1684/ejd.2024.4750.

A critical evaluation of suitability of tralokinumab for treatment of moderate-to-severe atopic dermatitis in adolescents and adults.对特利鲁单抗治疗青少年和成人中重度特应性皮炎的适宜性进行评价。

Expert Rev Clin Immunol. 2024 Mar;20(3):255-266. doi: 10.1080/1744666X.2023.2283585. Epub 2023 Nov 27.

Long-Term Disease Control and Minimal Disease Activity of Head and Neck Atopic Dermatitis in Patients Treated with Tralokinumab up to 4 Years.使用曲罗芦单抗治疗长达4年的头颈部特应性皮炎患者的长期疾病控制和最小疾病活动度

Am J Clin Dermatol. 2025 Mar 14. doi: 10.1007/s40257-025-00931-1.

Real-World Effectiveness and Safety of Dupilumab, Tralokinumab, and Upadacitinib in Patients with Atopic Dermatitis: A 52-Week International, Multicenter Retrospective Cohort Study.度普利尤单抗、曲罗芦单抗和乌帕替尼在特应性皮炎患者中的真实世界有效性和安全性：一项为期52周的国际多中心回顾性队列研究。

Dermatol Ther (Heidelb). 2025 Aug;15(8):2295-2305. doi: 10.1007/s13555-025-01453-8. Epub 2025 Jun 3.

Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study.曲罗芦单抗治疗特应性皮炎患者的多数治疗目标达成：一项多中心、多国、回顾性队列研究结果。

Expert Opin Biol Ther. 2023 Jul-Dec;23(12):1307-1315. doi: 10.1080/14712598.2023.2292627. Epub 2023 Dec 28.

Effectiveness of Tralokinumab in Different Phenotypes of Atopic Dermatitis: A Real-World Study.曲罗芦单抗在不同表型特应性皮炎中的有效性：一项真实世界研究。

Dermatol Ther (Heidelb). 2025 Feb;15(2):337-350. doi: 10.1007/s13555-025-01341-1. Epub 2025 Jan 25.

Effects of Tralokinumab on Clinical and Laboratory Indexes in Atopic Dermatitis: A 24-Week Real-World Study.曲罗芦单抗对特应性皮炎临床及实验室指标的影响：一项为期24周的真实世界研究。

Dermatitis. 2025 May-Jun;36(3):235-243. doi: 10.1089/derm.2024.0323. Epub 2024 Oct 3.

Effectiveness and Safety of Dupilumab and Tralokinumab for Treating Atopic Dermatitis and Pruritic Skin Disorders in Oncological Patients: A Narrative Review.度普利尤单抗和曲罗芦单抗治疗肿瘤患者特应性皮炎和瘙痒性皮肤病的有效性和安全性：一项叙述性综述

Clin Cosmet Investig Dermatol. 2025 Jan 30;18:311-317. doi: 10.2147/CCID.S511559. eCollection 2025.

The role of tralokinumab in the treatment of atopic dermatitis and future perspectives for adolescents.特罗利单抗在特应性皮炎治疗中的作用及青少年患者的未来前景。

Immunotherapy. 2023 Nov;15(16):1341-1349. doi: 10.2217/imt-2022-0307. Epub 2023 Aug 29.

引用本文的文献

Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review.特应性皮炎相关皮肤合并症的共享治疗方法：一项叙述性综述

Dermatol Ther (Heidelb). 2025 Oct 8. doi: 10.1007/s13555-025-01536-6.

The Use of JAK Inhibitors in Elderly Patients with Moderate-to-Severe Atopic Dermatitis: A Narrative Review of Clinical and Real-World Evidence.JAK抑制剂在中重度特应性皮炎老年患者中的应用：临床及真实世界证据的叙述性综述

J Clin Med. 2025 Sep 8;14(17):6327. doi: 10.3390/jcm14176327.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验